Clinical Trials Browser

OTHER_GOV × Interventional × Ovarian Neoplasms × Clear all

NCT07472140 2026-03-16

PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer

Phase 2/3 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05316181 2026-02-12

KOV-HIPEC-02R

Phase 3 Active not recruiting

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT07362147 2026-01-23

Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life

Phase NA Not yet recruiting

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases, Vaginal Neoplasms, Endometrial Neoplasms

NCT05236686 2025-11-19

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

Phase NA Recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Lymphatic Metastasis, Ovarian Neoplasms

NCT07171528 2025-09-12

KOV-02S

Phase 2 Recruiting

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT07105553 2025-08-06

NEURO-GLOVE

Phase NA Completed

Ovarian Neoplasms, Peripheral Nervous System Diseases, Endometrial Neoplasms

NCT07068464 2025-07-16

ICRA

Phase 3 Not yet recruiting

Ovarian Neoplasms

NCT06839144 2025-07-11

OC-POP-PT

Phase 2 Recruiting

Neoplasms, Ovarian Neoplasms

NCT06602063 2025-06-27

Surgery for Relapsed Ovarian Cancer in Precision

Phase 1/2 Not yet recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06879353 2025-03-19

Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery

Phase NA Completed

Ovarian Neoplasms

NCT06846424 2025-02-26

SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

Phase 1 Not yet recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05200260 2025-02-10

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Phase 2 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04846933 2025-01-16

DECIDER

Phase NA Recruiting

Ovarian Neoplasms

NCT04122235 2025-01-03

LETSGO

Phase NA Active not recruiting

Empowerment, Alzheimer Disease, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT02521844 2024-10-08

A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours

Phase 1 Active not recruiting

Ovarian Neoplasms, Endometrial Neoplasms

NCT04519151 2023-06-08

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

Phase 2 Recruiting

GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Genital Neoplasms, Female, Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Stomach Neoplasms, Urogenital Neoplasms

NCT05597527 2022-10-28

Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer

Phase 2 Unknown

Ovarian Neoplasms

NCT05564234 2022-10-04

Role of Laparoscopy in Assessing Resectability of Ovarian Cancer

Phase NA Completed

Ovarian Neoplasms

NCT01611766 2021-06-10

Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?

Phase 3 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT04461457 2020-07-08

Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2

Phase EARLY_PHASE1 Completed

Ovarian Neoplasms

NCT03150121 2020-02-26

BEDOCA

Phase NA Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms, Cystadenocarcinoma, Serous

NCT03942068 2019-05-08

Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer

Phase 2 Unknown

Ovarian Neoplasms

NCT03412526 2019-04-04

Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian

Phase 2 Unknown

Ovarian Neoplasms

NCT03547375 2018-06-06

Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy

Phase 2 Unknown

Ovarian Neoplasms

NCT01669226 2016-12-19

AICE

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02595021 2016-07-26

Total/Subtotal Colectomy in Ovarian Cancer

Phase 2 Unknown

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00532194 2015-09-23

ICON6

Phase 3 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01880996 2015-06-11

Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies

Phase 1/2 Withdrawn

Fatigue, Ovarian Neoplasms, Parasomnias

NCT00850772 2014-06-12

OPEN

Phase 3 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Malnutrition

NCT01654146 2012-07-31

ICON8

Phase 3 Unknown

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00533299 2007-09-21

Hydralazine Valproate for Ovarian Cancer

Phase 3 Unknown

Ovarian Neoplasms